1. van Dongen GA, Snow GB: Prospects for future studies in head and neck cancer. Eur J Surg Oncol. 1997, 23:486–491. This review outlines new therapeutic approaches to SCCHN including photodynamic therapy, gene therapy, and antibody therapy. The scientific concepts that form the bases for these approaches and the possible clinical applications are detailed.
2. Roth JA: Restoration of tumour suppressor gene expression for cancer. Forum (Geneva) 1998, 8:368–376.
3. Clayman GL, Lippman SM, Laramore GE, et al.: Head and neck cancer. In In Cancer Medicine, edn 4. Edited by Holland JF. Baltimore: Williams & Wilkins; 1997:1645–1710.
4. Schantz SP, Harrison LB, Forastiere AA: Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity and oropharynx. In In Cancer: Principles and Practice of Oncology, edn 5. Edited by DeVita VT, Hellman S, Rosenberg SA. Philadelphia: Lippincott-Raven; 1997:741–801.
5. Chang F, Syrjanen S, Syrjanen K: Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol 1995; 13:1009–1022.